Pliant Therapeutics, Inc.
PLRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $91 | $71 | $83 | $797 |
| - Cash | $94 | $87 | $92 | $71 |
| + Debt | $29 | $30 | $60 | $60 |
| Enterprise Value | $27 | $14 | $51 | $786 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$23 | -$42 | -$55 | -$48 |
| % Margin | – | – | – | – |
| Net Income | -$26 | -$43 | -$56 | -$50 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.43 | -0.71 | -0.92 | -0.82 |
| % Growth | 39.4% | 22.8% | -12.2% | – |
| Operating Cash Flow | -$21 | -$41 | -$49 | -$48 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$21 | -$41 | -$49 | -$48 |